Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs

Detalles Bibliográficos
Autores principales: Honickel, M, Grottke, O, Van Ryn, J, Ten Cate, H, Rossaint, R, Spronk, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068162/
http://dx.doi.org/10.1186/cc13289
_version_ 1782322392957190144
author Honickel, M
Grottke, O
Van Ryn, J
Ten Cate, H
Rossaint, R
Spronk, H
author_facet Honickel, M
Grottke, O
Van Ryn, J
Ten Cate, H
Rossaint, R
Spronk, H
author_sort Honickel, M
collection PubMed
description
format Online
Article
Text
id pubmed-4068162
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40681622014-07-03 Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs Honickel, M Grottke, O Van Ryn, J Ten Cate, H Rossaint, R Spronk, H Crit Care Poster Presentation BioMed Central 2014 2014-03-17 /pmc/articles/PMC4068162/ http://dx.doi.org/10.1186/cc13289 Text en Copyright © 2014 Honickel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Honickel, M
Grottke, O
Van Ryn, J
Ten Cate, H
Rossaint, R
Spronk, H
Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title_full Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title_fullStr Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title_full_unstemmed Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title_short Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
title_sort use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068162/
http://dx.doi.org/10.1186/cc13289
work_keys_str_mv AT honickelm useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs
AT grottkeo useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs
AT vanrynj useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs
AT tencateh useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs
AT rossaintr useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs
AT spronkh useofaspecificantidotetodabigatranidarucizumabreducesbloodlossandmortalityindabigatraninducedandtraumainducedbleedinginpigs

Ejemplares similares